These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 28013188)

  • 1. A capture method based on the VC1 domain reveals new binding properties of the human receptor for advanced glycation end products (RAGE).
    Degani G; Altomare AA; Colzani M; Martino C; Mazzolari A; Fritz G; Vistoli G; Popolo L; Aldini G
    Redox Biol; 2017 Apr; 11():275-285. PubMed ID: 28013188
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insights into the effects of N-glycosylation on the characteristics of the VC1 domain of the human receptor for advanced glycation end products (RAGE) secreted by Pichia pastoris.
    Degani G; Barbiroli A; Magnelli P; Digiovanni S; Altomare A; Aldini G; Popolo L
    Glycoconj J; 2019 Feb; 36(1):27-38. PubMed ID: 30612271
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advanced lipoxidation end products (ALEs) as RAGE binders: Mass spectrometric and computational studies to explain the reasons why.
    Mol M; Degani G; Coppa C; Baron G; Popolo L; Carini M; Aldini G; Vistoli G; Altomare A
    Redox Biol; 2019 May; 23():101083. PubMed ID: 30598328
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An improved expression system for the VC1 ligand binding domain of the receptor for advanced glycation end products in Pichia pastoris.
    Degani G; Colzani M; Tettamanzi A; Sorrentino L; Aliverti A; Fritz G; Aldini G; Popolo L
    Protein Expr Purif; 2015 Oct; 114():48-57. PubMed ID: 26118699
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prothrombin is a binding partner of the human receptor of advanced glycation end products.
    Degani G; Altomare A; Digiovanni S; Arosio B; Fritz G; Raucci A; Aldini G; Popolo L
    J Biol Chem; 2020 Aug; 295(35):12498-12511. PubMed ID: 32665403
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blocking the Interactions between Calcium-Bound S100A12 Protein and the V Domain of RAGE Using Tranilast.
    Chiou JW; Fu B; Chou RH; Yu C
    PLoS One; 2016; 11(9):e0162000. PubMed ID: 27598566
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Unveiling the molecular mechanisms underpinning biorecognition of early-glycated human serum albumin and receptor for advanced glycation end products.
    Tramarin A; Naldi M; Degani G; Lupu L; Wiegand P; Mazzolari A; Altomare A; Aldini G; Popolo L; Vistoli G; Przybylski M; Bartolini M
    Anal Bioanal Chem; 2020 Jul; 412(18):4245-4259. PubMed ID: 32367292
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A fragment-based approach to discovery of Receptor for Advanced Glycation End products inhibitors.
    Kozlyuk N; Gilston BA; Salay LE; Gogliotti RD; Christov PP; Kim K; Ovee M; Waterson AG; Chazin WJ
    Proteins; 2021 Nov; 89(11):1399-1412. PubMed ID: 34156100
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural insights into the oligomerization mode of the human receptor for advanced glycation end-products.
    Yatime L; Andersen GR
    FEBS J; 2013 Dec; 280(24):6556-68. PubMed ID: 24119142
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The pattern recognition reagents RAGE VC1 and peptide p5 share common binding sites and exhibit specific reactivity with AA amyloid in mice.
    Kennel SJ; Williams A; Stuckey A; Richey T; Wooliver C; Chazin W; Stern DA; Martin EB; Wall JS
    Amyloid; 2016; 23(1):8-16. PubMed ID: 26701064
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Trp triad within the V-domain of the receptor for advanced glycation end products modulates folding, stability and ligand binding.
    Indurthi VSK; Jensen JL; Leclerc E; Sinha S; Colbert CL; Vetter SW
    Biosci Rep; 2020 Jan; 40(1):. PubMed ID: 31912881
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Generation, biochemical characterizations and validation of potent nanobodies derived from alpaca specific for human receptor of advanced glycation end product.
    Mohammed A; Zeng W; Mengist HM; Kombe Kombe AJ; Ou H; Yang Y; Dan Z; Xu Z; Ma H; Jin T
    Biochem Biophys Res Commun; 2021 Dec; 581():38-45. PubMed ID: 34653677
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blocking the interface region amongst S100A6 and RAGE V domain via S100B protein.
    Sung HY; Dowarha D; Chou RH; Yu C
    Biochem Biophys Res Commun; 2020 Dec; 533(3):332-337. PubMed ID: 32958253
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural basis for pattern recognition by the receptor for advanced glycation end products (RAGE).
    Xie J; Reverdatto S; Frolov A; Hoffmann R; Burz DS; Shekhtman A
    J Biol Chem; 2008 Oct; 283(40):27255-69. PubMed ID: 18667420
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modeling the interaction between quinolinate and the receptor for advanced glycation end products (RAGE): relevance for early neuropathological processes.
    Serratos IN; Castellanos P; Pastor N; Millán-Pacheco C; Rembao D; Pérez-Montfort R; Cabrera N; Reyes-Espinosa F; Díaz-Garrido P; López-Macay A; Martínez-Flores K; López-Reyes A; Sánchez-García A; Cuevas E; Santamaria A
    PLoS One; 2015; 10(3):e0120221. PubMed ID: 25757085
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The receptor for advanced glycation end-products (RAGE) is an important pattern recognition receptor (PRR) for inflammaging.
    Teissier T; Boulanger É
    Biogerontology; 2019 Jun; 20(3):279-301. PubMed ID: 30968282
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advanced glycation end product recognition by the receptor for AGEs.
    Xue J; Rai V; Singer D; Chabierski S; Xie J; Reverdatto S; Burz DS; Schmidt AM; Hoffmann R; Shekhtman A
    Structure; 2011 May; 19(5):722-32. PubMed ID: 21565706
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The extracellular region of the receptor for advanced glycation end products is composed of two independent structural units.
    Dattilo BM; Fritz G; Leclerc E; Kooi CW; Heizmann CW; Chazin WJ
    Biochemistry; 2007 Jun; 46(23):6957-70. PubMed ID: 17508727
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of αX I-Domain Binding to Receptors for Advanced Glycation End Products (RAGE).
    Buyannemekh D; Nham SU
    Mol Cells; 2017 May; 40(5):355-362. PubMed ID: 28535664
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural insights into the binding of the human receptor for advanced glycation end products (RAGE) by S100B, as revealed by an S100B-RAGE-derived peptide complex.
    Jensen JL; Indurthi VS; Neau DB; Vetter SW; Colbert CL
    Acta Crystallogr D Biol Crystallogr; 2015 May; 71(Pt 5):1176-83. PubMed ID: 25945582
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.